Jump to Navigation
Deciphera

Secondary Menu

  • Home
  • Partners
  • News
  • Contact

Home

Deciphera Pharmaceuticals

is dedicated to the design, development and commercialization of unique kinase-inhibiting drugs for the treatment of cancers and immunological diseases. Learn More

Pipeline

News

All News

  • 02.01.2012
    Deciphera Pharmaceuticals Announces Collaboration Milestone with Eli Lilly and Company
    Read More
  • 07.18.2011
    Kansas Biosciences Authority Votes in Favor of a $1.6MM Product Development Grant to Deciphera.
    Read More
  • 07.06.2011
    Deciphera Pharmaceuticals and the University of Kansas Cancer Center team up for clinical study of leukemia drug
    Read More
  • 06.24.2011
    Deciphera Pharmaceuticals launches its updated website.
    Read More

Main menu

  • About Us
  • Technology
  • Pipeline
  • Clinical Trials

© 2011 Deciphera Pharmaceuticals, LLC. All Rights Reserved. Site by BOLD.